Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2019
Partial T Cell-Depleted Peripheral Blood Stem Cell Transplantation from HLA-Identical Sibling Donors for Patients with Severe Aplastic AnemiaJaime Sanz, Federico Moscardó, Juan Montoro, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2014
Effect of CD8⁺ cell content on umbilical cord blood transplantation in adults with hematological malignanciesFederico Moscardó, Jaime Sanz, Francisco Carbonell, et al.
Annals of Hematology|April 22, 2021
Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myelomaMaría José Cejalvo, Gabriela Bustamante, Esther González, et al.
Leukemia & Lymphoma|July 4, 2018
Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantationSamuel Romero, Juan Montoro, Marta Guinot, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Refractoriness to eltrombopag in adult primary immune thrombocytopenia: utility of next-generation sequencing techniquesTomás José González-López, Ricardo Sanchez, Carmen Pastoriza, et al.
Diagnostics (Basel, Switzerland)|April 23, 2022
Panel Sequencing for Clinically Oriented Variant Screening and Copy Number Detection in Chronic Lymphocytic Leukemia PatientsMariam Ibáñez, Esperanza Such, Alessandro Liquori, et al.
Blood Cells, Molecules & Diseases|September 26, 2020
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patientsMaria L Lozano, Maria E Mingot-Castellano, María M Perera, et al.
Leukemia & Lymphoma|August 20, 2025
Patient-reported outcomes in relapsed/refractory diffuse large B-cell lymphoma with odronextamab monotherapyElżbieta Iskierka-Jażdżewska, Won Seog Kim, Seok-Goo Cho, et al.
Cancer Medicine|October 28, 2017
Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphomaAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Pageof 12